GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of genuine question about EU that I am slightly embarrassed to ask — 6 comments in the full submission. View in context.
0
c/glp1eu·submitted 1 months ago by u/solene_ilunga

genuine question about EU that I am slightly embarrassed to ask

Questionbranch of 6 comments

genuine question about EU that I am slightly embarrassed to ask. I am not trying to be the "source?" guy. I would just like a source. Assumed a prescription would be honoured across the border. It was not, and the rules are clear once you actually read them. The variation between pharmacies inside my own country was…

Read the full submission and all 6 comments →

This branch

6 comments, started 29 days ago
u/vikram_asante3 points·29 days ago

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

replysharereportpermalink
u/joaquin_trevino1 point·29 days ago·edited

pharmacy margins are regulated differently in each country

replysharereportpermalink
[removed]1 point·29 days ago

[removed by moderator]

replysharereportpermalink
u/tove_ogunleye1 point·29 days ago

Published reimbursement criteria exist in most member states and are usually available in the national language.

vikram_asante is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/dario_petrescu1 point·29 days ago

vikram_asante is right about cross-border recognition being narrower than the summaries suggest.

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
u/naomi_erdogan4 points·29 days ago

What does the local patient information leaflet say?

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/glp1eu
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/eu_apotheke_au/nl_verzekeringu/nordic_pricingu/spain_receta
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →